Ligand Pharmaceuticals
LGND
#2855
Rank
NZ$10.35 B
Marketcap
NZ$516.76
Share price
-1.00%
Change (1 day)
129.04%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2026 (TTM): NZ$0.32 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.27 Billion. In 2025 the company made an earning of NZ$0.28 Billion, an increase over its 2024 earnings that were of NZ$9.58 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.32 B15.79%
2025 NZ$0.28 B2848.57%
2024 NZ$9.58 M-91.37%
2023 NZ$0.11 B-7.59%
2022 NZ$0.12 B4%
2021 NZ$0.11 B296.42%
2020 NZ$29.16 M-97.97%
2019 NZ$1.43 B275.62%
2018 NZ$0.38 B237.48%
2017 NZ$0.11 B49.05%
2016 NZ$76.1 M55.41%
2015 NZ$48.97 M36.87%
2014 NZ$35.78 M29.59%
2013 NZ$27.61 M1309.35%
2012 NZ$1.95 M-43.97%
2011 NZ$3.49 M-113.19%
2010 -NZ$26.52 Million59.86%
2009 -NZ$16.59 Million-61.33%
2008 -NZ$42.89 Million-58.75%
2007 -NZ$0.11 Billion20.52%
2006 -NZ$86.26 Million81.27%
2005 -NZ$47.59 Million
2003 -NZ$33.14 Million-20.6%
2002 -NZ$41.73 Million4.38%
2001 -NZ$39.98 Million-48.83%
2000 -NZ$78.12 Million-19.74%
1999 -NZ$97.33 Million-19.06%
1998 -NZ$0.13 Billion126.71%
1997 -NZ$53.04 Million-5.83%
1996 -NZ$56.32 Million136.23%
1995 -NZ$23.85 Million-33.97%
1994 -NZ$36.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$44.88 B 13,538.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$18.29 B 5,460.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$53.77 B 16,240.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.69 B 4,670.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-NZ$0.88 Billion-366.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$22.72 B 6,804.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$16.57 B 4,938.43%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$17.29 B 5,155.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-NZ$0.11 Billion-132.49%๐Ÿ‡บ๐Ÿ‡ธ USA